Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Abstract 4993: Novel fully human anti-GD2 monoclonal antibodies with potent therapeutic activity against neuroblastoma, sarcoma and melanoma

Govind Ragupathi, Xiaohong Wu, Ritsuko Sawada, Philip O. Livingston, Wolfgang W. Scholz

Cancer Res (2016) 76 (14_Supplement): 4993.

https://doi.org/10.1158/1538-7445.AM2016-4993

Published: 15 July 2016

View articletitled, Abstract 4993: Novel fully human anti-GD2 monoclonal antibodies with potent therapeutic activity against neuroblastoma, sarcoma and melanoma

Journal Articles

Abstract 2417: Preclinical evaluation of potential novel synthetic saponin adjuvants with conjugate cancer vaccines

Govind Ragupathi, Payal Damani, Nicholas R. Perl, Annie Won, David Y. Gin, Philip O. Livingston

Cancer Res (2010) 70 (8_Supplement): 2417.

https://doi.org/10.1158/1538-7445.AM10-2417

Published: 15 April 2010

View articletitled, Abstract 2417: Preclinical evaluation of potential novel synthetic saponin adjuvants with conjugate cancer vaccines

Journal Articles

Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

Govind Ragupathi, Fusataka Koide, Beatrice Wt Yin, Kenneth O. Lloyd, Drew Hannaman, Philip O. Livingston

Cancer Res (2006) 66 (8_Supplement): 331–332.

Published: 15 April 2006

View articletitled, Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

Journal Articles

Botanicals as immunological adjuvants and immunomodulators.

Philip O. Livingston, Chandra Hood, Govind Ragupathi

Cancer Res (2006) 66 (8_Supplement): 1306–1307.

Published: 15 April 2006

View articletitled, Botanicals as immunological adjuvants and immunomodulators.

Journal Articles

Preclinical evaluation of fully synthetic Globo H cluster carbohydrate antigen as a cancer vaccine

Fusataka Koide, Govind Ragupathi, Stacy J Keding, Jennifer Allen, Samuel J. Danishefsky, Philip O. Livingston

Cancer Res (2006) 66 (8_Supplement): 332.

Published: 15 April 2006

View articletitled, Preclinical evaluation of fully synthetic Globo H cluster carbohydrate antigen as a cancer vaccine

Journal Articles

GD2 antibodies prevent tumor recurrence after foot-pad challenge followed by amputation despite impact of micrometastases

Fusataka Koide, John Gathuru, Soo-Kie Kim, Govind Ragupathi, Nai-Kong Cheung, Philip O. Livingston

Cancer Res (2005) 65 (9_Supplement): 165.

Published: 01 May 2005

View articletitled, GD2 antibodies prevent tumor recurrence after foot-pad challenge followed by amputation despite impact of micrometastases

Journal Articles

Preclinical evaluation of fully synthetic unimolecular penta-antigenic carbohydrate antigen as a cancer vaccine

Govind Ragupathi, Fusataka Koide, Stacy Keding, Jennifer Allen, Samuel J. Danishefsky, Philip O. Livingston

Cancer Res (2005) 65 (9_Supplement): 1216.

Published: 01 May 2005

View articletitled, Preclinical evaluation of fully synthetic unimolecular penta-antigenic carbohydrate antigen as a cancer vaccine

Journal Articles

A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

Richard Lo-Man, Sophie Vichier-Guerre, Ronald Perraut, Edith Dériaud, Valérie Huteau, Lbachir BenMohamed, Ousmane M. Diop, Philip O. Livingston, Sylvie Bay, Claude Leclerc

Cancer Res (2004) 64 (14): 4987–4994.

https://doi.org/10.1158/0008-5472.CAN-04-0252

Published: 15 July 2004

View articletitled, A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

Journal Articles

Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity

John K. Gathuru, Fusataka Koide, Govind Ragupathi, Janet A. Dawson, Timothy P. Coleman, Philip O. Livingston

Cancer Res (2004) 64 (7_Supplement): 292.

Published: 01 April 2004

View articletitled, Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity

Journal Articles

Searching for a better synthetic Lewis y (Le^y) analogue to immunize patient with Le^y positive cancers

Govind Ragupathi, Fusataka Koide, Maria Spassova, William G. Bornmann, Samuel J. Danishefsky, Philip O. Livingston

Cancer Res (2004) 64 (7_Supplement): 1264–1265.

Published: 01 April 2004

View articletitled, Searching for a better synthetic Lewis y (Ley) analogue to immunize patient with Ley positive cancers

Journal Articles

Antibodies against GD2 Ganglioside Can Eradicate Syngeneic Cancer Micrometastases

Helen Zhang, Shengle Zhang, Nai-Kong V. Cheung, Govindaswami Ragupathi, Philip O. Livingston

Cancer Res (1998) 58 (13): 2844–2849.

Published: 01 July 1998

View articletitled, Antibodies against GD2 Ganglioside Can Eradicate Syngeneic Cancer Micrometastases

Journal Articles

Augmenting the Immunogenicity of Synthetic MUC1 Peptide Vaccines in Mice

Shengle Zhang, Linda A. Graeber, Friedhelm Helling, Govindaswami Ragupathi, Sucharita Adluri, Kenneth O. Lloyd, Philip O. Livingston

Cancer Res (1996) 56 (14): 3315–3319.

Published: 01 July 1996

View articletitled, Augmenting the Immunogenicity of Synthetic MUC1 Peptide Vaccines in Mice

Journal Articles

Immune Sera and Monoclonal Antibodies Define Two Configurations for the Sialyl Tn Tumor Antigen

Shengle Zhang, Linda A. Walberg, Shunichiro Ogata, Steven H. Itzkowitz, R. Rao Koganty, Mark Reddish, Sham S. Gandhi, B. Michael Longenecker, Kenneth O. Lloyd, Philip O. Livingston

Cancer Res (1995) 55 (15): 3364–3368.

Published: 01 August 1995

View articletitled, Immune Sera and Monoclonal Antibodies Define Two Configurations for the Sialyl Tn Tumor Antigen

Journal Articles

G_M2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21

Friedhelm Helling, Shengle Zhang, Ann Shang, Sucharita Adluri, Michele Calves, Rao Koganty, B. Michael Longenecker, Tzy-J. Yao, Herbert F. Oettgen, Philip O. Livingston

Cancer Res (1995) 55 (13): 2783–2788.

Published: 01 July 1995

View articletitled, GM2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21

Journal Articles

G_D3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines

Friedhelm Helling, Ann Shang, Michele Calves, Shengle Zhang, Shunlin Ren, Robert K. Yu, Herbert F. Oettgen, Philip O. Livingston

Cancer Res (1994) 54 (1): 197–203.

Published: 01 January 1994

View articletitled, GD3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines

Journal Articles

Immunization of Colorectal Cancer Patients with Modified Ovine Submaxillary Gland Mucin and Adjuvants Induces IgM and IgG Antibodies to Sialylated Tn

Kevin P. O'Boyle, Rochelle Zamore, Sucharita Adluri, Alfred Cohen, Nancy Kemeny, Sydney Welt, Kenneth O. Lloyd, Herbert F. Oettgen, Lloyd J. Old, Philip O. Livingston

Cancer Res (1992) 52 (20): 5663–5667.

Published: 01 October 1992

View articletitled, Immunization of Colorectal Cancer Patients with Modified Ovine Submaxillary Gland Mucin and Adjuvants Induces IgM and IgG Antibodies to Sialylated Tn

Journal Articles

Biochemical and Serological Characteristics of Natural 9-O-Acetyl GD3 from Human Melanoma and Bovine Buttermilk and Chemically O-Acetylated GD3

Gerd Ritter, Erika Boosfeld, Ellen Markstein, Robert K. Yu, Shunlin Ren, William B. Stallcup, Herbert F. Oettgen, Lloyd J. Old, Philip O. Livingston

Cancer Res (1990) 50 (5): 1403–1410.

Published: 01 March 1990

View articletitled, Biochemical and Serological Characteristics of Natural 9-O-Acetyl GD3 from Human Melanoma and Bovine Buttermilk and Chemically O-Acetylated GD3

Journal Articles

Characterization of IgG and IgM Antibodies Induced in Melanoma Patients by Immunization with Purified G_m2 Ganglioside¹

Philip O. Livingston, Gerd Ritter, Pramod Srivastava, Maureen Padavan, Michele J. Calves, Herbert F. Oettgen, Lloyd J. Old

Cancer Res (1989) 49 (24_Part_1): 7045–7050.

Published: 15 December 1989

View articletitled, Characterization of IgG and IgM Antibodies Induced in Melanoma Patients by Immunization with Purified Gm2 Ganglioside1

Journal Articles

A Murine Monoclonal Antibody Detecting N-Acetyl- and N-Glycolyl-G_M2: Characterization of Cell Surface Reactivity

Edward J. Natoli, Jr., Philip O. Livingston, Clifford S. Pukel, Kenneth O. Lloyd, Herbert Wiegandt, Jeanne Szalay, Herbert F. Oettgen, L. J. Old

Cancer Res (1986) 46 (8): 4116–4120.

Published: 01 August 1986

View articletitled, A Murine Monoclonal Antibody Detecting N-Acetyl- and N-Glycolyl-GM2: Characterization of Cell Surface Reactivity

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 4993: Novel fully human anti-GD2 monoclonal antibodies with potent therapeutic activity against neuroblastoma, sarcoma and melanoma

Abstract 2417: Preclinical evaluation of potential novel synthetic saponin adjuvants with conjugate cancer vaccines

Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

Botanicals as immunological adjuvants and immunomodulators.

Preclinical evaluation of fully synthetic Globo H cluster carbohydrate antigen as a cancer vaccine

GD2 antibodies prevent tumor recurrence after foot-pad challenge followed by amputation despite impact of micrometastases

Preclinical evaluation of fully synthetic unimolecular penta-antigenic carbohydrate antigen as a cancer vaccine

A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity

Searching for a better synthetic Lewis y (Le^y) analogue to immunize patient with Le^y positive cancers

Antibodies against GD2 Ganglioside Can Eradicate Syngeneic Cancer Micrometastases

Augmenting the Immunogenicity of Synthetic MUC1 Peptide Vaccines in Mice

Immune Sera and Monoclonal Antibodies Define Two Configurations for the Sialyl Tn Tumor Antigen

G_M2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21

G_D3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines

Immunization of Colorectal Cancer Patients with Modified Ovine Submaxillary Gland Mucin and Adjuvants Induces IgM and IgG Antibodies to Sialylated Tn

Biochemical and Serological Characteristics of Natural 9-O-Acetyl GD3 from Human Melanoma and Bovine Buttermilk and Chemically O-Acetylated GD3

Characterization of IgG and IgM Antibodies Induced in Melanoma Patients by Immunization with Purified G_m2 Ganglioside¹

A Murine Monoclonal Antibody Detecting N-Acetyl- and N-Glycolyl-G_M2: Characterization of Cell Surface Reactivity

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only